CYP3A4-V and prostate cancer in African Americans: Causal or confounding association because of population stratification?

Human Genetics

Volumn 110, Issue 6, 2002, Pages 553-560

  Kittles, Rick A ^a,b,c   Chen, Weidong ^a   Panguluri, Ramesh K ^a   Ahaghotu, Chiledum ^b,c   Jackson, Aaron ^b   Adebamowo, Clement A ^d   Griffin, Robin ^a   Williams, Tyisha ^a   Ukoli, Flora ^c   Adams Campbell, Lucile ^c   Kwagyan, John ^a   Isaacs, William ^e   Freeman, Vincent ^f   Dunston, Georgia M ^a,c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c HOWARD UNIVERSITY CANCER CENTER   (United States)

^d UNIVERSITY OF IBADAN   (Nigeria)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHROMOSOME; CONTROLLED STUDY; ETHNIC GROUP; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NEGRO; POPULATION GENETIC STRUCTURE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SAMPLE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; DNA, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; NIGERIA; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; UNITED STATES; VARIATION (GENETICS);

EID: 0036626714     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0731-5     Document Type: Article

References (53)

1. Amirimani B, Walker AH, Weber BL, Rebbeck TR (1999) Response to Ando et al. Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 91:1588-1590
2. Ando Y, Tateishi T, Sekido Y, Yamamoto T, Satoh T, Hasegawa Y, et al. (1999) Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 91:1587-1588
3. Ball SE, Scatina J, Kao J, Ferron GM, Fruncillo R, Mayer P, et al. (1999) Population distribution and effects on drug metabolism of a genetic variant in the 5′ promoter region of CYP3A4. Clin Pharmacol Ther 66:288-294
4. Briscoe D, Stephens JC, O'Brien SJ (1994) Linkage disequilibrium in admixed populations: Applications in gene mapping. J Hered 85:59-63
5. Chakraborty R, Weiss KM (1988) Admixture as a tool for finding linked genes and detecting that difference from allelic association between loci. Proc Natl Acad Sci USA 85:9119-9123
6. Collins FS, Guyer MS, Chakravarti A (1997) Variations on a theme: Cataloging human DNA sequence variation. Science 278:1580-1581
7. Collins-Schramm H, Phillips C, Operario D, Lee J, Weber J, Hanson R, Knowler W, Cooper R, Li H, Seldin M (2002) Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet 70:737-750
8. Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55:997-1004
9. Ewens WJ, Spielman RS (1995) The transmission/disequilibrium test: History, subdivision, and admixture. Am J Hum Genet 57:455-464
10. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320-3323
11. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. Cancer J Clin 50:7-33
12. Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche M (2000) A polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 87:434-437
13. Habuchi T, Liqing Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, Shimoda N, Satoh S, Sato K, Kakehi Y, Kamoto T, Ogawa O, Kato T (2000) Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. Cancer Res 60:5710-5713
14. Irvine RA, Yu MC, Ross RK, Coetze GA (1995) The CAG and GGC and microsatellites are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937-1940
15. Jaffe J, Malkowicz B, Walker A, MacBride S, Peschel R, Tomaszewski J, Arsdalen K, Wein A, Rebbeck T (2000) Association of SRD5A2 Genotype and Pathological Characteristics of Prostate Tumors. Cancer Research 60:1626-30
16. Kittles R, Young D, Weinrich S, Hudson J, Aryropoulos G, Ukoli F, Adams-Campbell L, Dunston G (2001a) Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: Implications for prostate cancer risk. Hum Genet 109:253-261
17. Kittles R, Panguluri R, Chen W, Massac A, Ahaghotu C, Jackson A, Ukoli F, Adams-Campbell L, Isaacs W, Dunston G (2001b) CYP17 promoter variant associated with prostate cancer aggressiveness in African Americans. Cancer Epidemiol Biomarkers Prev 10:943-947
18. Kruglyak L (1999) Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22:139-144
19. Lander ES, Schork NJ. (1994) Genetic dissection of complex traits. Science 265:2037-2048
20. Lee S-T, Nicholls R, Jong M, Fukai K, Spritz R (1995) Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics 26:354-363
21. Mastana SS, Constans J, Papiha SS (1996) New rare variants and interpretation of the genetic diversity at the group-specific component GC locus in populations of India. Hum Biol 685:795-818
22. Morton NE, Collins A (1998) Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci USA 11389-11393
23. Paris PL, Kupelian PA, Hall JM, Williams TL, Levin H, Klein EA, Casey G, Witte JS (1999) Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol Biomarkers Prev 8:901-905
24. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, Shriver MD (1998) Estimating African admixture proportions by use of population-specific alleles. Am J Hum Genet 63:1839-1851
25. Parra EJ, Kittles R, Argyropoulos G, Hiester K, Bonilla C, Sylvester N, Parrish-Gause D, Garvey W, Kamboh M, Jin L, Ferrell R, Pollitzer W, Mckeighe P, Shriver MD (2001) Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. American Journal of Physical Anthropology 114:18-29
26. Pfaff C, Parra E, Bonilla C, Hiester K, McKeigue P, Kamboh M, Hutchinson R, Ferrell R, Boerwinkle E, Shriver MD (2001) Population structure in admixed populations: Effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet 68:198-207
27. Pfaff C, Kittles R, Shriver MD (2002) Adjusting for population structure in admixed populations. Genet Epidemiol 22:196-198
28. Pritchard JK, Rosenberg NA (1999) Use of unliked genetic markers to detect population stratification in association studies. Am J Hum Genet 65:220-228
29. Pritchard JK, Stephens MD, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945-959
30. Rebbeck TR (2000) More about: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 92:76
31. Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB (1998) Modification of clinical presentation of prostate tumors by a novel genetic variant CYP9A4. J Natl Cancer Inst 90:1225-1229
32. Reich D, Goldstein D (2001) Detecting association in a case-control study while correcting for population stratification. Genet Epidemiol 20:4-16
33. Reich D, Goldstein D (2002) Re: Adusting for population structure in admixed populations. Genet Epidemiol 22:198-200
34. Reichardt JKV, Makridakis N, Henderson B, Yu M, Pike M, Ross R (1995) Genetic variability of the human SRD5A2 gene: Implications for prostate cancer risk. Cancer Res 55:3973-3975
35. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Edwards BK (2000) SEER Cancer Statistics Review, 1973-1997. National Cancer Institute, Bethesda, MD., USA
36. Risch NJ (2000) Searching for genetic determinants in the new millenium. Nature 405:847-856
37. Risch NJ, Teng J (1998) The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. I. DNA pooling. Genome Res 8:1273-1288
38. Ross RK, Coetzee GA, Reichardt JK, Skinner E, Henderson BE (1995) Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer 75:1778-1782
39. Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN, Henderson BE (1998) Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility. Cancer Res 58:4497-4404
40. Sartor O, Zheng O, Eastham J (1999) Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer. Urology 53:378-380
41. Schork NJ, Fallin D, Thiel B, Xu X, Broeckel U, Jacob HJ, Cohen D (2001) The future of genetic case-control studies. Adv Genet 42:191-192
42. Smith JR, Freije D, Carpten JD, Xu J, Isaacs SD, Brownstein MJ et al (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274:1371-1374
43. Spielman RS, Ewens WJ (1998) A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test. Am J Hum Genet 62:450-458
44. Stephens JC, Briscoe D, O'Brien SJ (1994) Mapping by admixture linkage disequilibrium in human populations: Limits and guidelines. Am J Hum Genet 55:809-824
45. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayanath P, et al (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27:172-180
46. Wacholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias. J Natl Cancer Inst 92:1151-1158
47. Walker AH, Jaffe JM, Gunasegaram S, Cummings SA, Huang C, Chern H, Olopade OI, Weber BL, Rebbeck TR (1998) Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: Ethnic distribution and implications for prostate cancer risk. Hum Mutat 12:289
48. Waxman DJ, Attisano C, Guengerich FP, Laperson DP (1998) Human liver microsomal steroid meetabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys 263:424-436
49. Westlind A, Loftberg L, Tindberg N, Anderson TB, Ingelman-Sundberg M (1999) Interindividual differences in hepatic expression of CYP3A4: Relationship to genetic polymorphism in the 5′-upstream regulatory region. Biochem Biophys Res Commun 259:201-205
50. Williams RC, Long JC, Hanson RL, Sievers ML, Knowler W (2000) Individual estimates of European genetic admixture associated with lower body-mass index, plasma glucose, and prevalence of type 2 diabetes in Pima Indians. Am J Hum Genet 66:527-538
51. Xu J, Meyers D, Freije D, Isaacs S, Wiley S, Nusskern D, Ewing C, et al (1998) Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20:175-179
52. Zheng C, Elston R (1999) Multipoint linkage disequilibrium mapping with particular reference to the African American population. Genet Epidemiol 17:79-101
53. Zheng L, Lee WH (2001) The retinoblastoma gene: A prototypic and multifunctional tumor suppressor. Exp Cell Res 264:2-18